US Anticoagulation Market
US Anticoagulation Market Research Report Information by Drug Class (Novel and Direct Anticoagulants [DOACs], Heparin and Low Molecular Weight [LMWH], Warfarin, Vitamin K Antagonists), Disease Indication(Anti Fibrillation [A-Fib], Stroke, Deep Vein Thrombosis/Pulmonary Embolism [PE], Mechanical Heart Valves [MHV]), Route of Administration (Oral and Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region (North America, Europe, Asia-Pacific, and Rest of the World)โForecast till 2030
US Anticoagulation Market Highlighted Trends & Dynamics
As per MRFR analysis, the Size was estimated at 8.59 (USD Billion) in 2024. The Industry is expected to grow from 9.41 (USD Billion) in 2025 to 21.43 (USD Billion) till 2034, at a CAGR (g..